Clonexpress, inc. Email Format
Biotechnology ResearchMaryland, United States2-10 Employees
Clonexpress, inc., based in Gaithersburg, Maryland, operates a biotechnology research platform that generates patient-specific differentiated cell types through epigenetic induction. It has developed patient-specific pancreatic beta cells, hepatocytes, and dopaminergic neurons from adult human fibroblasts and peripheral blood mononuclear cells, and has produced cell lines closely resembling primary cells that are available for licensing or purchase for drug discovery and toxicology testing. A recent development is a human microglial cell line available for licensing. The company offers custom cell line development from client-provided tumor samples and primary cells, for research use. In addition, it supplies human CNS primary cells and other cell types for research, and has identified a cancer growth-control mechanism that is not present in normal cells, along with a sensitive assay to identify targets, and it is seeking partnerships to advance this work.